How can early development of sound clinical and ethical expectations for a clinical trial drive better outcomes?
TORONTO (PRWEB) January 27, 2021
How are clinical trials with increased patient diversity leading to more successful treatments? While industry progress towards diverse clinical trials has been slow, there are many inspiring cases where more inclusive patient populations have been used to provide effective treatments for the communities that need them. How can early development of sound clinical and ethical expectations for a clinical trial drive better outcomes? What difference does it make to apply business intelligence and analytics to the challenges of diversity? Join this discussion with industry experts to learn how clinical trial Sponsors, study sites, and other support teams have made this work.
This four-part webinar series will identify obstacles that continue to stifle appropriate patient diversity in clinical trials; unpacking the organizational overhaul needed to effect change; sharing case studies where sponsors, patients, and investigators have come together to overcome hurdles; and exploring how policy innovations that might include government-led mandates and incentives can move the industry forward as one.
Join moderator Nicholas Kenny, Chief Scientific Officer, Syneos Health; Lorena Kuri, Head, Diversity Strategy, Bristol-Myers Squibb; Bassel Nazha, MD, MPH, Assistant Professor, Department of Hematology and Medical Oncology, Emory-Winship Cancer Center; and Diana L. Foster, PhD, Vice President of Strategy and Development, Society for Clinical Research Sites in a live webinar on Wednesday, February 10, 2021 at 12pm EST.
For more information, or to register for this event, visit When It All Works: Case Studies for Success With Patient Diversity in Clinical Trials.
Blazing a Trail to Clinical Trial Diversity Webinar Series
This four-part webinar series will identify obstacles that have to-date, and continue to, stifle appropriate patient diversity in clinical trials; unpacking the organizational overhaul needed to effect change; sharing case studies where sponsors, patients and investigators have come together to overcome hurdles; and exploring how policy innovations that might include government-led mandates and incentives can move the industry forward as one. Speakers include experts from the Association for Clinical Research Professionals (ACRP), Bristol Myers Squibb, Emory-Winship Cancer Center, Incyte Corporation, NCI Community Oncology Research Program (NCORP) and the Society for Clinical Research Sites (SCRS).
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
About Syneos Health
Syneos Health® is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. We bring together approximately 24,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together, we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are Shortening the distance from lab to life®, visit syneoshealth.com or subscribe to our podcast.